Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02512419 · ClinicalTrials.gov registry record · NA
Developing a Text-Message Enhanced Physical Activity Intervention for Latino Men
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT02512419: Completed NA study, sponsored by University of California, San Diego.
NCT02512419 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02512419, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The aim of this study is to build upon our tailored print intervention by developing new text-delivered intervention materials to complement our print-based physical activity (PA) intervention. In Phase 1 we will conduct 6 focus groups with Mexican and Mexican American (MA) men to determine content, frequency, and types of text messages desired, and to identify cultural themes to incorporate into existing and new materials. Themes from the focus groups and sample text messages will be presented to a confirmatory focus group panel. Phase 2 will be a 6-month pilot randomized controlled trial with Mexican and MA men (N=60) to test the text-enhanced, Spanish language, individually tailored PA intervention vs. publicly available, Spanish language health education materials, including information on PA, diet, and stress management. This will be followed by post-intervention qualitative interviews to solicit suggestions for improvements to help further refine the program. The proposed pilot will support a future R01 to establish the efficacy of this multi-media, multi-level PA intervention for Mexican and MA men.
Primary Outcome
Participants will wear an Actigraph GT3X+ accelerometer, which measures movement and intensity of activity and has been validated against heart rate telemetry and total energy expenditure.
Interventions
- BEHAVIORAL Text-Enhanced Physical Activity Intervention Arm
- BEHAVIORAL Health Education Control Arm
- DEVICE Actigraph GT3X
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-12-31 |
| Phase | NA |
What the finished NCT02512419 record still lists
NCT02512419 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Text-Enhanced Physical Activity Intervention Arm is the first listed.
NCT02512419 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02512419 about?
NCT02512419 is a clinical study titled "Developing a Text-Message Enhanced Physical Activity Intervention for Latino Men". The aim of this study is to build upon our tailored print intervention by developing new text-delivered intervention materials to complement our print-based physical activity (PA) intervention. In Phase 1 we will conduct 6 focus groups with Mexican and Mexican American (MA) men to determine content,...
What is the current status of trial NCT02512419?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2015-07. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT02512419?
The interventions under investigation include: Text-Enhanced Physical Activity Intervention Arm (BEHAVIORAL), Health Education Control Arm (BEHAVIORAL), Actigraph GT3X (DEVICE).
Who is sponsoring clinical trial NCT02512419?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02512419's enrollment target sits among peer trials
48 1381st of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia